Status:
WITHDRAWN
The Effect of Intermittent Fasting on Body Composition in Women With Breast Cancer
Lead Sponsor:
Duke University
Conditions:
Breast Cancer
Eligibility:
FEMALE
20-70 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate intermittent fasting after the treatment of breast cancer with surgery and radiation therapy. All participants will either delay their first meal of the day ...
Eligibility Criteria
Inclusion
- biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast stage I-III
- completed any chemotherapy prior to initiation of the trial (adjuvant endocrine therapy is permitted)
- BMI \> 25 kg/m2 or body fat% greater or equal to 31%
- have a schedule amenable to nutrition and dietitian counseling described within the study protocol as determined by the treating radiation oncologist
- have access to the internet and email with capability to join Zoom calls
Exclusion
- Metastatic breast cancer
- Currently receiving chemotherapy
- Uncontrolled hypertension or diabetes, defined as systolic blood pressure over 149, diastolic blood pressure over 99, or hemoglobin A1c greater than 8.9.
- Diabetic condition requiring the usage of insulin
Key Trial Info
Start Date :
December 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04691999
Start Date
December 2 2021
End Date
August 1 2023
Last Update
November 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Center
Durham, North Carolina, United States, 27710